Human Basic Fibroblast Growth Factor Gene Transfer Induces Angiogenesis in Ischemic Heart

LIU Yong,HUANG Zhi-jun,YUAN Hong,WU Xiao-bin,PENG Jian-qiang,YANG Guo-ping

DOI: https://doi.org/10.3969/j.issn.1672-2019.2006.01.007

2006-01-01

Abstract:s: [Objective] To investigate the effect on ischemic myocardium of human basic fibroblast growth factor (hbFGF) cDNA mediated by recombinant adeno-associated viral vector2 (rAAV-2). [Methods] Rabbit myocardial ischemic models were generated by ligation of the anterior descending coronary artery. All these forty models were randomly divided into 4 groups: FGF high dose group (1012 v.g./kg), FGF middle dose group (1011 v.g./kg), FGF low dose group (1010 v.g/kg) and control group. RAAV-2/hbFGF or PBS was injected into the ischemic myocardium respectively. After 4 weeks, the expression of objective gene was evaluated by RT-PCR. Myocardial capillary counts were calculated to evaluate the proangiogenic effects. [Results] The expression levels of hbFGF mRNA were increased with the increasing dosage of injected rAAV-2/hbFGF. The changes of expression were dose-dependent and there were significant differences among the groups(P 0.05). In rAAV-2/hbFGF 1010, 1011 and 1012 v.g./kg treatment groups, the microvessel counts were(4.52±1.37)/HPF, (10.78±1.62)/HPF and (18.64±3.32)/HPF respectively, while (4.46±1.42)/HPF in control group. There was significant differences between the 1011, 1012 v.g./kg hbFGF gene-treated groups and control group(both P 0.05), but no such difference between between 1010 v.g./kg hbFGF gene-treated group and control group(P 0.05). [Conclusions] HbFGF gene mediated by rAAV-2 can be efficiently transferred into rabbit ischemic heart and induce angiogenesis of myocardium successfully. The proangiogenic effect of hbFGF gene mediated by rAAV-2 is in a dose-independent manner.